Your browser doesn't support javascript.
loading
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome.
Park, Yeon Hee; Lal, Samir; Lee, Jeong Eon; Choi, Yoon-La; Wen, Ji; Ram, Sripad; Ding, Ying; Lee, Soo-Hyeon; Powell, Eric; Lee, Se Kyung; Yu, Jong Han; Ching, Keith A; Nam, Jae-Yong; Kim, Seok Won; Nam, Seok Jin; Kim, Ji-Yeon; Cho, Soo Youn; Park, Seri; Kim, Jinho; Hwang, Soohyn; Kim, Yu Jin; Bonato, Vinicius; Fernandez, Diane; Deng, Shibing; Wang, Shuoguo; Shin, Hyuntae; Kang, Eun-Suk; Park, Woong-Yang; Rejto, Paul A; Bienkowska, Jadwiga; Kan, Zhengyan.
Affiliation
  • Park YH; Samsung Medical Center, Seoul, Korea. yhparkhmo@skku.edu.
  • Lal S; Oncology Research & Development, Pfizer, San Diego, CA, USA.
  • Lee JE; Samsung Medical Center, Seoul, Korea.
  • Choi YL; Samsung Medical Center, Seoul, Korea.
  • Wen J; Oncology Research & Development, Pfizer, San Diego, CA, USA.
  • Ram S; Drug Safety R&D, Pfizer, San Diego, CA, USA.
  • Ding Y; Oncology Research & Development, Pfizer, San Diego, CA, USA.
  • Lee SH; Pfizer Oncology, Seoul, Korea.
  • Powell E; Oncology Research & Development, Pfizer, San Diego, CA, USA.
  • Lee SK; Samsung Medical Center, Seoul, Korea.
  • Yu JH; Samsung Medical Center, Seoul, Korea.
  • Ching KA; Oncology Research & Development, Pfizer, San Diego, CA, USA.
  • Nam JY; Samsung Medical Center, Seoul, Korea.
  • Kim SW; Samsung Medical Center, Seoul, Korea.
  • Nam SJ; Samsung Medical Center, Seoul, Korea.
  • Kim JY; Samsung Medical Center, Seoul, Korea.
  • Cho SY; Samsung Medical Center, Seoul, Korea.
  • Park S; Samsung Medical Center, Seoul, Korea.
  • Kim J; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Hwang S; Samsung Medical Center, Seoul, Korea.
  • Kim YJ; Samsung Medical Center, Seoul, Korea.
  • Bonato V; Biostatistics, Pfizer, San Diego, CA, USA.
  • Fernandez D; Oncology Research & Development, Pfizer, San Diego, CA, USA.
  • Deng S; Biostatistics, Pfizer, San Diego, CA, USA.
  • Wang S; Oncology Research & Development, Pfizer, San Diego, CA, USA.
  • Shin H; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Kang ES; Samsung Medical Center, Seoul, Korea.
  • Park WY; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Rejto PA; Oncology Research & Development, Pfizer, San Diego, CA, USA.
  • Bienkowska J; Oncology Research & Development, Pfizer, San Diego, CA, USA.
  • Kan Z; Oncology Research & Development, Pfizer, San Diego, CA, USA. zhengyan.kan@pfizer.com.
Nat Commun ; 11(1): 6175, 2020 12 02.
Article in En | MEDLINE | ID: mdl-33268821
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / Lymphocytes, Tumor-Infiltrating / Carcinoma, Ductal, Breast / Neoadjuvant Therapy / B7-H1 Antigen Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / Lymphocytes, Tumor-Infiltrating / Carcinoma, Ductal, Breast / Neoadjuvant Therapy / B7-H1 Antigen Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2020 Document type: Article Country of publication: